Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 2
Submit an article Journal homepage
289
Views
10
CrossRef citations to date
0
Altmetric
Letter to the Editor

A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma

Jason A. TrubianoDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaCorrespondence[email protected]
,
Anupkumar GeorgeDivision of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
,
Jennifer BarnettMicrobiology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
,
Mahendra SiwanMicrobiology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
,
Alexander HeriotDivision of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
,
H. Miles PrinceDivision of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia;The University of Melbourne, Parkville, Victoria, Australia
,
Monica A. SlavinDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia;Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
&
Benjamin W. TehDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
 show all
Pages 512-514 | Received 19 Mar 2014, Accepted 28 Apr 2014, Published online: 15 Jul 2014

References

  • Trubiano JA, Worth LJ, Thursky KA, et al. The prevention and management of infections due to multi-drug-resistant organisms in haematology patients. Br J Clin Pharmacol 2013 Dec 17. [Epub ahead of print]
  • Parmar SR, Bhatt V, Yang J, et al. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. J Oncol Pharm Pract 2014;20:172–182.
  • Gough E, Shaikh H, Manges A. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994–1002.
  • Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 2014 Jan 16. [Epub ahead of print]
  • van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal donor-feces infusion for recurrent C. difficile. N Engl J Med 2013;368: 407–415.
  • Neemann K, Eichele DD, Smith PW, et al. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogenic stem cell transplant patient. Transplant Infect Dis 2012;14:E161–E165.
  • Alonso CD, Treadway SB, Hanna DB, et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2012;54:1053–1063.
  • Willems L, Porcher R, Lafaurie M, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation:incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2012;18:1295–1301.
  • Cornely OA, Miller M, Fantin B, et al. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol 2013;31:2493–2499.
  • Louie TJ, Miller MA, Mullane KM, et al.; OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011;364:422–431.
  • Clutter DS, Dubrovskaya Y, Meri MY, et al. Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother 2013;79: 4501–4505.
  • Trubiano JA, Gardiner B, Kwong JC, et al. Faecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit. Eur J Gastroenterol Hepatol 2013;25:255–257.
  • Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, et al. Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex 2012;77: 40–42.
  • You D, Franzos M, Holman R. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med 2008;148:632–633.
  • Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003;36:580–585.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.